Eritrea vs Kazakhstan: Cause of death, by non-communicable diseases, ages 15-59, male
Eritrea
46.2%
in 2021
Kazakhstan
46.9%
in 2021
Eritrea rank
109th
Kazakhstan rank
107th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Eritrea
- Kazakhstan
How they compare
Kazakhstan currently reports 46.9% against 46.2% in Eritrea, a difference of 0.7%.
Across all 6 years both countries report, Kazakhstan has been ahead every year.
Eritrea ranks 109th and Kazakhstan ranks 107th of 185 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 59.0% | 20.0% | Kazakhstan |
| 2010s | 45.8% | 67.1% | 21.3% | Kazakhstan |
| 2020s | 46.9% | 52.8% | 5.9% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Eritrea or Kazakhstan?
- Kazakhstan, at 46.9% against 46.2% in Eritrea as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Eritrea and Kazakhstan?
- 0.7%, with Kazakhstan ahead.
- How many years of comparable data are there for Eritrea and Kazakhstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Eritrea and Kazakhstan rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Eritrea ranks 109th and Kazakhstan ranks 107th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.